Mon premier blog

CHANGE CONTROL FOR FDA REGULATED INDUSTRIES: A RISK ASSESMENT APPROACH by David N. Muchemu

CHANGE CONTROL FOR FDA REGULATED INDUSTRIES: A RISK ASSESMENT APPROACH David N. Muchemu ebook
Page: 148
Format: pdf
Publisher: Authorhouse
ISBN: 9781434314673

Feb 17, 2011 - In that context, risk management can exploit information from structured quantitative sources (numerical data) and semantic unstructured sources (e.g. Jan 7, 2014 - “Inadequate dissemination of the regulatory requirement by the regulator and frequent changes in the requirements contribute to the increase in FDA warning letters,” says Dilip Shah, CEO at Vision Consulting Group. The assessment would take “We are moving away from our 'one-size-fits-all' approach to clinical trial outcomes for these devices,” FDA officials wrote. Text, voice or video recordings) for driving risk assessment and risk . Oct 1, 2009 - seek changes as necessary. Initial ideas of quality risk management and its incorporation into pharmaceutical quality development started with ICH Q8, Q9 and Q10 standards and separate agency initiatives (e.g. Demand response, for example, .. Nov 14, 2013 - How can we minimize regulatory risk to our company, comply with requirements, but still control associated costs? Mar 25, 2013 - In order to support innovation, science-based decision making, optimize regulatory assessment and reduce post-approval administrative burden authorities worldwide try to support the use of risk-based tools in developing pharmaceuticals. Apr 14, 2014 - Sticking regulatory fences into the fertile plains of software development and low-cost devices will arouse its untamed denizens, who are already lobbying Congress to warn the FDA about overreaching. The HHS report does find a role for “conformity assessment,” including certifications and accreditation, and it was highlighted in a teleconference they held Thursday, but I question how far one can apply it to fast-changing software. Dec 11, 2013 - Assessments for drug responses carry the risks that patients relying on such tests may begin to self-manage their treatments through dose changes or even abandon certain therapies depending on the outcome of the assessment. Barriers to Demand Resources: The Commission will continue its efforts to identify and eliminate barriers to participation by demand resources in organized wholesale electric markets. One common approach to assess exposure of a drug manufacturing facility to regulatory compliance risks is to conduct a Facility Quality Systems Audit. Dec 13, 2013 - Agency officials late last year proposed a benefit-risk assessment that they say would provide a more consistent pathway to approval. In this blog we will explore strategic and tactical approaches to managing FSMA regulatory compliance, looking at both the currently enacted regulations, such as the Whistleblower Provision and Biennial Registration, and the Finally, a valuable planning exercise to take before rushing to implement changes at the company is Gap Assessment. Both the FDA and the model by Yu et al rely on a qualitative classification of audit findings. New approaches are all over the map: Namely, I'm OK with heavy government regulation of drugs (in principle—I have enormous problems with how the FDA does things in practice today, but that's a separate discussion!). STRATEGY | Use a risk-based approach to plan and prioritize audits of jurisdictional companies. ¤ By FY 2014, 80 percent of the Commission's audit program will be planned using a risk-based approach.